4,167
Views
30
CrossRef citations to date
0
Altmetric
Review

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates

ORCID Icon & ORCID Icon
Pages 2359-2377 | Received 25 Apr 2019, Accepted 27 Jul 2019, Published online: 07 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Mehedy Hasan Abir, Tanjilur Rahman, Ayan Das, Silvia Naznin Etu, Iqbal Hossain Nafiz, Ahmed Rakib, Saikat Mitra, Talha Bin Emran, Kuldeep Dhama, Ariful Islam, Abolghasem Siyadatpanah, Shafi Mahmud, Bonlgee Kim & Mohammad Mahmudul Hassan. (2022) Pathogenicity and virulence of Marburg virus. Virulence 13:1, pages 609-633.
Read now
Ranjit Sah, Aroop Mohanty, Abdullah Reda, Abdelmonem Siddiq, Ranjan K. Mohapatra & Kuldeep Dhama. (2022) Marburg virus re-emerged in 2022: recently detected in Ghana, another zoonotic pathogen coming up amid rising cases of Monkeypox and ongoing COVID-19 pandemic- global health concerns and counteracting measures. Veterinary Quarterly 42:1, pages 167-171.
Read now
Daniel N. Wolfe, Marva J. Taylor & Amanda G. Zarrabian. (2020) Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus. Human Vaccines & Immunotherapeutics 16:11, pages 2855-2860.
Read now
Joel N. Maslow. (2019) Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases. Human Vaccines & Immunotherapeutics 15:10, pages 2230-2234.
Read now

Articles from other publishers (26)

Lesley C Dupuy, Christina F Spiropoulou, Jonathan S Towner, Jessica R Spengler, Nancy J Sullivan & Joel M Montgomery. (2023) Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation. The Journal of Infectious Diseases 228:Supplement_6, pages S446-S459.
Crossref
Shiza Malik & Yasir Waheed. (2023) Tracing down the updates on Ebola virus surges: An update on anti-ebola therapeutic strategies. Journal of Translational Internal Medicine 11:3, pages 216-225.
Crossref
Manish P Mane Manohar, Vivian J Lee, Ejikeme U Chinedum Odunukwe, Pratik K Singh, Buhlebethu S Mpofu & Christine Oxley, MD. (2023) Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review. Cureus.
Crossref
Faisal F. Albaqami, Ali Altharawi, Hassan N. Althurwi, Khalid M. Alharthy, Muhammad Qasim, Ziyad Tariq Muhseen & Muhammad Tahir ul Qamar. (2023) Computational Modeling and Evaluation of Potential mRNA and Peptide-Based Vaccine against Marburg Virus (MARV) to Provide Immune Protection against Hemorrhagic Fever. BioMed Research International 2023, pages 1-18.
Crossref
Khaled Albakri, Momen Al-Hajali, Othman Saleh, Ayah M. Alkhalil, Ahmed B. Mohd, Carla A. Samain, Nadeen N. Abuasad, Hanan Hasan, Abdulrhman Khaity & Ramadan A. Farahat. (2023) Marburg virus disease treatments and vaccines: recent gaps and implications. Annals of Medicine & Surgery 85:2, pages 328-330.
Crossref
Vladimir A. Markin. (2022) Marburg virus and the disease it causes. Journal of microbiology, epidemiology and immunobiology 99:5, pages 605-618.
Crossref
Bilha Baby, Rajalakshmi Rajendran, Manju M. Nair & Roshni P. Raghavan. (2022) Sagacious Perceptive on Marburg Virus Foregrounding the Recent Findings: A Critical Review. Infectious Disorders - Drug Targets 22:8.
Crossref
Prabin Baral, Elumalai Pavadai, Ziyou Zhou, Yang Xu, Christopher K. Tison, Rudramani Pokhrel, Bernard S. Gerstman & Prem P. Chapagain. (2022) Immunoinformatic screening of Marburgvirus epitopes and computational investigations of epitope-allele complexes. International Immunopharmacology 111, pages 109109.
Crossref
Ranjan K. Mohapatra, Ashish K. Sarangi, Venkataramana Kandi, Sandip Chakraborty, Deepak Chandran, Mahmoud Alagawany, Chiranjib Chakraborty & Kuldeep Dhama. (2022) Recent re-emergence of Marburg virus disease in an African country Ghana after Guinea amid the ongoing COVID-19 pandemic: Another global threat? Current knowledge and strategies to tackle this highly deadly disease having feasible pandemic potential. International Journal of Surgery 106, pages 106863.
Crossref
Sylvie Chabot, Yusra Gimie, Karam Obeid, Jaekwan Kim, Clement A. Meseda, Krishnamurthy Konduru, Gerardo Kaplan, Li Sheng Fowler, Jerry P. Weir, Keith Peden & Marian E. Major. (2022) Enhanced In Vitro and In Vivo Potency of a T Cell Epitope in the Ebola Virus Glycoprotein Following Amino Acid Replacement at HLA-A*02:01 Binding Positions . Journal of Virology 96:18.
Crossref
Sandip Chakraborty, Deepak Chandran, Ranjan K. Mohapatra, Mahmoud Alagawany, Mohd Iqbal Yatoo, Md. Aminul Islam, Anil K. Sharma & Kuldeep Dhama. (2022) Marburg Virus Disease – A Mini-Review. Journal of Experimental Biology and Agricultural Sciences 10:4, pages 689-696.
Crossref
Courtney L. Finch, William E. Dowling, Thomas H. King, Christian Martinez, Bai V. Nguyen, Ramon Roozendaal, Roxana Rustomjee, Mario H. Skiadopoulos, Ekaterina Vert-Wong, Ann Yellowlees & Nancy J. Sullivan. (2022) Bridging Animal and Human Data in Pursuit of Vaccine Licensure. Vaccines 10:9, pages 1384.
Crossref
Roberto Biselli, Roberto Nisini, Florigio Lista, Alberto Autore, Marco Lastilla, Giuseppe De Lorenzo, Mario Stefano Peragallo, Tommaso Stroffolini & Raffaele D’Amelio. (2022) A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health. Biomedicines 10:8, pages 2050.
Crossref
Adewusi John Adepoju, Dayo Felix Latona, Oluwafemi Gbenga Olafare, Abel Kolawole Oyebamiji, Misbaudeen Abdul-Hammed & Banjo Semire. (2022) Molecular docking and pharmacokinetics studies of Curcuma longa (Curcumin) potency against Ebola virus . Ovidius University Annals of Chemistry 33:1, pages 22-35.
Crossref
Anthony R. Rees. 2022. A New History of Vaccines for Infectious Diseases. A New History of Vaccines for Infectious Diseases 369 394 .
Oyelola Adegboye, Matt A. Field, Andreas Kupz, Saparna Pai, Dileep Sharma, Michael J. Smout, Phurpa Wangchuk, Yide Wong & Claire Loiseau. (2021) Natural-Product-Based Solutions for Tropical Infectious Diseases. Clinical Microbiology Reviews 34:4.
Crossref
Ashish Ranjan Sharma, Yeon-Hee Lee, Sudarshini Nath & Sang-Soo Lee. (2021) Recent developments and strategies of Ebola virus vaccines. Current Opinion in Pharmacology 60, pages 46-53.
Crossref
Marco Cosentino, Marco Ferrari & Franca Marino. (2021) Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals. Journal of Neuroimmune Pharmacology 16:3, pages 517-518.
Crossref
Emma M. Bentley, Samuel Richardson, Mariliza Derveni, Pramila Rijal, Alain R. Townsend, Jonathan L. Heeney, Giada Mattiuzzo & Edward Wright. (2021) Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay. Tropical Medicine and Infectious Disease 6:3, pages 155.
Crossref
Betsy Yang & Kuender D. Yang. (2021) Immunopathogenesis of Different Emerging Viral Infections: Evasion, Fatal Mechanism, and Prevention. Frontiers in Immunology 12.
Crossref
Zhikang Yu, Heming Wu, Qingyan Huang & Zhixiong Zhong. (2021) Simultaneous detection of Marburg virus and Ebola virus with TaqMan‐based multiplex real‐time PCR method. Journal of Clinical Laboratory Analysis 35:6.
Crossref
N. V. Volkova, O. V. Pyankov, A. V. Ivanova, A. A. Isaeva, A. V. Zybkina, E. I. Kazachinskaya & D. N. Shcherbakov. (2021) Prototype of a DNA Vaccine against Marburg Virus. Bulletin of Experimental Biology and Medicine 170:4, pages 475-478.
Crossref
Mitchell P. Christy, Yoshinori Uekusa, Lena Gerwick & William H. Gerwick. (2020) Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2. Journal of Natural Products 84:1, pages 161-182.
Crossref
Bo Liang. (2020) Structures of the Mononegavirales Polymerases . Journal of Virology 94:22.
Crossref
Pengyan Wang & William J. Liu. (2020) It’s not just science: Challenges for public health intervention in Ebola epidemics in the Democratic Republic of Congo. Science China Life Sciences 63:7, pages 1079-1081.
Crossref
S. A. Melnikov, I. V. Borisevich, E. V. Rozhdestvensky, V. B. Pantyukhov, N. K. Chernikova, E. V. Gordeev, S. A. Nimirskaya, A. L. Khmelev, S. I. Syromyatnikova, I. V. Shatokhina, T. M. Plekhanova, G. D. Timankova, S. V. Borisevich, D. A. Kutaev, L. F. Stovba & E. Yu. Mishalova. (2020) Properties of Heterologous anti-Ebola Immunoglobulin after Long Storage. BIOpreparations. Prevention, Diagnosis, Treatment 20:1, pages 50-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.